Metlife Inc Income Statement Quarterly
MET
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
Premiums earned |
11,786.00 |
11,230.00 |
11,678.00 |
9,589.00 |
9,358.00 |
Other Revenue |
1,876.00 |
-189.00 |
-127.00 |
1,154.00 |
2,494.00 |
Investments Gain (Loss), Net |
5,366.00 |
4,825.00 |
5,072.00 |
4,645.00 |
4,464.00 |
Total Revenue |
19,028.00 |
15,866.00 |
16,623.00 |
15,388.00 |
16,316.00 |
Cost of Revenues |
159.00 |
153.00 |
151.00 |
159.00 |
967.00 |
Policyholder Benefits and Claims Incurred, Net |
11,779.00 |
11,130.00 |
11,809.00 |
9,872.00 |
9,636.00 |
Gross
profit |
7,090.00 |
4,583.00 |
4,663.00 |
5,357.00 |
7,647.00 |
Selling, Administration, Marketing |
- |
- |
- |
- |
- |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Impairment charges |
- |
- |
- |
- |
- |
Other exp. /-income |
- |
-813.00 |
-833.00 |
179.00 |
- |
Restructuring Charges |
- |
- |
- |
- |
- |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Other loss/ -income |
6,149.00 |
37.00 |
5,066.00 |
276.00 |
3,986.00 |
Total costs & expenses |
18,087.00 |
15,332.00 |
16,193.00 |
15,131.00 |
14,589.00 |
Income /-loss before income taxes |
941.00 |
534.00 |
430.00 |
257.00 |
1,727.00 |
Income taxes expenses/-benefit |
327.00 |
39.00 |
22.00 |
172.00 |
381.00 |
Income after income taxes |
614.00 |
495.00 |
408.00 |
85.00 |
1,346.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
614.00 |
495.00 |
408.00 |
85.00 |
1,346.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
614.00 |
495.00 |
408.00 |
85.00 |
1,346.00 |
Noncontrolling interests |
7.00 |
6.00 |
6.00 |
5.00 |
3.00 |
Prefered dividends |
33.00 |
67.00 |
32.00 |
66.00 |
29.00 |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
574.00 |
422.00 |
370.00 |
14.00 |
1,314.00 |
EBIT |
941.00 |
534.00 |
430.00 |
257.00 |
1,727.00 |
EBITD |
1,659.00 |
534.00 |
430.00 |
257.00 |
2,400.00 |
EBITDA |
1,659.00 |
534.00 |
430.00 |
257.00 |
2,400.00 |
Per
Share (GAAP Quarterly, in $) |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
Basic EPS (excl. extra
items) |
0.76 |
0.56 |
0.48 |
0.02 |
1.64 |
Extraordinary items |
0.05 |
0.00 |
0.00 |
0.00 |
0.03 |
Basic Net EPS |
0.71 |
0.56 |
0.48 |
0.02 |
1.61 |
Basic shares outstanding (Mill.
of Units) |
808.56 |
753.57 |
770.83 |
700.00 |
814.33 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
0.71 |
0.56 |
0.48 |
0.02 |
1.61 |
Diluted average shares (Mill.
of Units) |
762.43 |
753.57 |
770.83 |
700.00 |
808.93 |
Dividend per share |
0.463 |
0.431 |
0.518 |
0.556 |
0.486 |
|
|